Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Metatrol Pro is a super-concentrated dietary supplement containing Fermented Wheat Germ Extract-Super Concentrate (FWGE-SC), developed for supportive care in cancer patients. It is produced through a specialized process that removes gluten and non-active components from standard fermented wheat germ extract, resulting in a more potent formulation that requires a significantly lower dosage than traditional FWGE products. Metatrol Pro works by modulating glucose metabolism in malignant cells, specifically by inhibiting enzymes in the pentose phosphate pathway such as glucose-6-phosphate dehydrogenase (G6PD) and transketolase, which limits the availability of ribose for DNA synthesis. Additionally, it enhances the immune system's anti-tumor response by increasing natural killer (NK) cell activity and downregulating the expression of MHC class I molecules on the surface of cancer cells, thereby improving immune recognition. It is marketed by Indochina Healthcare as a supportive nutritional intervention to support metabolic health and immune function in individuals undergoing cancer treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Metatrol Pro.